Diabetic Macular Edema Management

Optometry
Curriculum:
Then, Now, and Tomorrow: Evolving the Management of Diabetic: Retinopathy and the Role of the Optometrist
Credits:
0.5 COPE
Launch Date:
April 06, 2020
Expiration Date:
March 31, 2021

Primary Audience:

Optometrists

Relevant Terms:

Diabetic macular edema, Macular edema, Diabetic retinopathy, Retinopathy

Eric Nudleman, MD, PHD

Shiley Eye Institute
University of California San Diego
La Jolla, California

1. Understand the evolving treatment paradigm of diabetic eye disease.
2. Explain to patients the need for early and timely referral to retina specialists.

 
Evolve is an approved COPE Administrator

This course is COPE approved for .5 hours of CE Credit for Optometrists.

COPE Course ID: 67765-PS

COPE Activity ID #119209

 

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

Faculty and Disclosures

Eric Nudleman, MD, PhD 

Shiley Eye Institute

University of California San Diego

La Jolla, California

 

Eric Nudleman, MD, PhD, and/or spouse; has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, and Regeneron.

 
Editorial Support Disclosures

The staff and planners involved in this activity have no financial relationships with commercial interests.

 
Grantor Statement

This educational activity is supported by a medical educational grant from Regeneron Pharmaceuticals and Carl Zeiss Meditec.

 

Off-Label Statement
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Regeneron Pharmaceuticals or Carl Zeiss Meditec.

 

COURSE VIEWING REQUIREMENTS

Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above